CytoMed Therapeutics Limited
- GDTC
- NASDAQ
- Biotechnology
- Cellular Immunotherapy
- Pre-Clinical Biotech
$0.85
Today −3.17%Quote Oct 19, 2026, 08:00 PM UTC
−0.69%over the last month
Max drawdown −19.7%From 1-month high −12.9%3 months −10.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About CytoMed Therapeutics
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
42
Founded
2018
Market value
$10.1M
Quote Oct 19
Floor
$0.80
6.0% below price
Resistance
$0.92
7.6% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GDTCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free